In addition to PD1/PDL1 and CTLA4, other “metabolic checkpoints” (e.g., mTOR, PGC-1α, IDO1, LDH) have been identified as affecting the competition between cancer and infiltrating immune cells for nutrients and metabolites (44–46). The gene discussed is CTLA4; the disease is cancer.